Jingao Li

机构：Jiangxi Provincial Cancer Hospital · ORCID：0000-0002-0389-7576

发表论文 157 篇 · 总被引 5720 次 · h-index 27

代表论文

• Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma (2025 · JAMA · 被引 26)
• Vacancy-mediated electromagnetic loss tuning in Cr-doped lanthanum manganite perovskites for broadband and high-intensity microwave absorption (2025 · Journal of Advanced Ceramics · 被引 11)
• MRPL21-PARP1 axis promotes cisplatin resistance in head and neck squamous cell carcinoma by inhibiting autophagy through the PI3K/AKT/mTOR signaling pathway (2025 · Journal of Experimental & Clinical Cancer Research · 被引 11)
• Sequential vs Induction Plus Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma (2025 · JAMA Oncology · 被引 8)
• Becotatug vedotin vs. chemotherapy in pre-heavily treated advanced nasopharyngeal carcinoma: A randomized, controlled, multicenter, open-label study. (2025 · Journal of Clinical Oncology · 被引 6)
• Tagitanlimab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (R/M NPC): Results from a randomized, double-blind, phase 3 study. (2025 · Journal of Clinical Oncology · 被引 4)